BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
Bit Digital
BTBT
$520M
| $5.14M | ﹤0.01% |
710,685
+28,709
| +4% | +$277K |
|
3852
Rallybio
RLYB
$90.1M
| $5.14M | ﹤0.01% |
+36,526
| New | +$4.28M |
|
3853
Schwab US Broad Market ETF
SCHB
$45.2B
| $5.12M | ﹤0.01% |
295,722
-11,886
| -4% | -$211K |
|
|
ZEPP
3854
Zepp Health
ZEPP
$78.6M
| $5.1M | ﹤0.01% |
158,745
+7,385
| +5% | +$305K |
|
|
TLIS
3855
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $5.08M | ﹤0.01% |
54,209
+389
| +0.7% | +$51.8K |
|
3856
Barings BDC
BBDC
$987M
| $5.07M | ﹤0.01% |
459,578
+47,248
| +11% | +$509K |
|
3857
Disc Medicine
IRON
$3.07B
| $5.05M | ﹤0.01% |
41,638
-282
| -0.7% | -$38.5K |
|
3858
Innodata
INOD
$2.03B
| $5.04M | ﹤0.01% |
529,143
-300
| -0.1% | -$2.3K |
|
|
FNCH
3859
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $5.04M | ﹤0.01% |
12,911
+363
| +3% | +$155K |
|
|
RERE
3860
ATRenew
RERE
$1.02B
| $5.01M | ﹤0.01% |
500,000
| – | – |
|
|
WBK
3861
DELISTED
Westpac Banking Corporation
WBK
| $5M | ﹤0.01% |
269,911
+4,049
| +2% | +$75.6K |
|
3862
Zevia
ZVIA
$101M
| $5M | ﹤0.01% |
+434,141
| New | +$5.76M |
|
3863
Montauk Renewables
MNTK
$268M
| $4.99M | ﹤0.01% |
+444,457
| New | +$3.79M |
|
3864
Provident Financial
PROV
$113M
| $4.99M | ﹤0.01% |
296,241
+13,440
| +5% | +$230K |
|
3865
LSB Industries
LXU
$711M
| $4.98M | ﹤0.01% |
633,841
+160,749
| +34% | +$1M |
|
3866
Western Midstream Partners
WES
$20B
| $4.96M | ﹤0.01% |
236,461
+242
| +0.1% | +$4.82K |
|
3867
Build-A-Bear
BBW
$474M
| $4.92M | ﹤0.01% |
290,635
+728
| +0.3% | +$11.9K |
|
3868
Goldman Sachs BDC
GSBD
$1.12B
| $4.92M | ﹤0.01% |
267,979
+23,822
| +10% | +$456K |
|
|
ACTDU
3869
DELISTED
ArcLight Clean Transition Corp. II Unit
ACTDU
| $4.89M | ﹤0.01% |
496,849
-3,151
| -0.6% | -$31.4K |
|
|
CNVY
3870
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $4.88M | ﹤0.01% |
+581,597
| New | +$5.18M |
|
|
SIC
3871
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
| $4.88M | ﹤0.01% |
338,548
+11,922
| +4% | +$152K |
|
3872
Culp Inc
CULP
$43.2M
| $4.87M | ﹤0.01% |
378,165
-5,563
| -1% | -$78.2K |
|
3873
iShares International Developed Real Estate ETF
IFGL
$82.3M
| $4.87M | ﹤0.01% |
174,001
+45,801
| +36% | +$1.36M |
|
3874
Carlyle Secured Lending
CGBD
$782M
| $4.86M | ﹤0.01% |
362,265
+34,893
| +11% | +$476K |
|
|
MESO
3875
Mesoblast
MESO
$2.14B
| $4.85M | ﹤0.01% |
403,735
+13,016
| +3% | +$181K |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.